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Stenting or balloon angioplasty of stenosed 
autologous saphenous vein grafts in pigs 
In a model of early and aggressive vein graft stenosis in pigs, an intervention was performed 
with a single stent (n = 12 grafts), multiple stents (n = 6), or balloon angioplasty (n = 6), while 
grafts with mild stenoses were left untreated (n = 6). Four weeks after intervention, angiography 
showed that grafts with single stents, balloon angioplasty, or untreated grafts had patency rates 
of 92%, 83%, and 83%, respectively. Grafts receiving multiple stents, however, showed only a 
17% patency rate (p < 0.05). Balloon dilatation or placement of a single stent improved the 
angiographic minimal diameter by 0.6 + 0.2 and 0.8 k 0.3 mm, respectively, over the short term, 
but this gain was lost during the follow-up period. Multiple stents showed a similar gain 
(0.5 + 0.2 mm) but more loss occurred during the follow-up period (2.4 t 0.2 mm). Histology 
revealed no significant differences between the treatment groups except for the prolonged 
presence of thrombus remnants in association with the stent wires. In conclusion, single stents 
and balloon angioplasty show good patency in early saphenous vein graft narrowing but multiple 
stents show a high occlusion rate. (AM HEART J 1994;127:273-81.) 
Heleen M. M. van Beusekom, MSc, Patrick W. Serruys, MD, Johannes C. Post, MD, 
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Rotterdam, The Netherlands 
Coronary artery bypass graft (CABG) operations us- 
ing autologous saphenous veins are a widely em- 
ployed surgical therapy for obstructive atheroscle- 
rotic coronary artery disease. Up to 12% of grafts, 
however, occlude within 1 month after the operation, 
with an additional 10 % occlusion rate during the first 
year. A subsequent yearly occlusion rate of 2% has 
been reported, resulting in a 65% patency rate at 5 
years. I, 2 Repeat byp ass surgery is feasible in most 
cases, but is associated with an increased morbidity 
and mortality, while long-term patency is inferior to 
that of the first procedure.3-5 Moreover, a significant 
number of patients for several reasons are poor can- 
didates for repeat surgery.6 Percutaneous translumi- 
nal coronary angioplasty (PTCA) may be an alterna- 
tive to surgery in these patients. The initial success 
rate of this procedure is high (90 % ), but the resteno- 
sis rate after PTCA in bypass graft is considerable, 
and only 41% of patients are alive and event-free af- 
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ter 2 years7 Additionally, not all patients are candi- 
dates for balloon angioplasty.6 
The implantation of endovascular prostheses, also 
called stents, seems a promising new technique for 
treatment and prevention of restenosis in these pa- 
tients.8p g The angiographic and histologic results af- 
ter stent implantation in bypass grafts have only 
been reported to a limited extent.g-12 We therefore 
studied the placement of stents in an animal model 
for autologous saphenous vein graftingI and com- 
pared the results with those of balloon angioplasty 
alone, or with those following no intervention at all. 
METHODS 
Vein graft model. Experiments were performed in 31 
Yorkshire pigs (17 to 30 kg; HVC, Hedel, The Nether- 
lands). The protocol was approved by the Committee on 
Experimental Animals of Erasmus University. After an 
overnight fast the animals were sedated with 20 mg/kg 
ketamine hydrochloride (Ketalin; Apharmo BV, Arnhem, 
The Netherlands). Following endotracheal intubation, the 
pigs were connected to a ventilator that administered a 
mixture of oxygen and nitrous oxide (1:2, vol/vol). Anes- 
thesia was maintained with 1 to 4 ~01% enflurane (Ethrane; 
Abbot BV, Maalderij, The Netherlands). Antibiotic pro- 
phylaxis was administered by an intramuscular injection of 
1000 mg of a mixture of penicillin G procaine and penicil- 
lin G benzathine (Duplocillin; Gist-Brocades NV, Delft, 
The Netherlands). 
The implantation of two venous grafts was performed 
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Fig. 1. Schematic representation of the vein graft model 
showing how the vein is interposed in the carotid artery. 
(Courtesy of Professor G. D. Angelini, Bristol, England.) 
according to the methods described by Angelini et aLI3 
(Fig. 1). Briefly, skin incisions were made parallel to and 
approximately 3 cm lateral to the trachea on both sides. 
Both common carotid arteries were dissected free over a 
length of approximately 4 cm and were subsequently cov- 
ered with gauze soaked in a 1% papaverine solution (Pa- 
parini sulfas; Centrafarm BV, Etten-leur, The Nether- 
lands) to prevent vasospasm. The vena saphena minor of 
the left leg was prepared free over a distance of approxi- 
mately 5 cm and the larger side branches were secured. Af- 
ter removal, the vein was overdistended using a syringe 
containing a solution of 1% papaverine and 10 U/ml of 
heparin (Thromboliquine; Organon Teknika BV, Boxtel, 
The Netherlands). Thereafter two pieces of vein, approx- 
imately 15 mm in length, were excised and stored in the 
same solution. After cross clamping of one carotid artery, 
a 15 mm piece of the vessel was removed and was replaced 
by a piece of saphenous vein by two end-to-end anasto- 
moses using a 6.0 suture (Prolene; Ethicon, Norderstedt, 
Germany). After intravenous administration of 2500 U of 
heparin, the clamps were released. The contralateral ca- 
rotid artery was grafted in an identical way. The anasto- 
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motic sites were marked with stainless steel hemoclips. 
Neck and leg wounds were closed in layers using catgut 
(Chronic Gut; American Cyanamid Co., Wayne, N.J.) and 
the skin was covered with antiseptic spray (Nobecutane; 
Astra Pharmaceutics BV, Rijswijk, The Netherlands). 
Thereafter the animals were allowed to recover from anes- 
thesia. Two animals died during the first days after surgery. 
Follow-up angiography. Four weeks after surgery 29 
animals were anesthetized as described above. Under ster- 
ile conditions an arteriotomy of a femoral artery was per- 
formed and a 9F introduction sheath was inserted. Then 
5000 IU of heparin sodium was administered and an 8F 
guiding catheter was advanced to the aortic arch. After 
measurement of arterial blood pressure and heart rate and 
withdrawal of an arterial blood sample for the measure- 
ment of blood gases and acid-base balance (settings of the 
ventilator corrected, if necessary), angiography of the 
grafted carotid arteries was performed using iopamidol 
(Iopamiro 370; Dagra, Diemen, The Netherlands) as a con- 
trast agent. Only animals with at least one patent graft were 
used for further study. One animal with two patent grafts 
was excluded from the study because of infection. In this 
animal the acute effect of 2 hours of stent placement was 
studied by scanning electron microscopy. 
Balloon-expandable stent. The balloon-expandable 
stent used in this study (Wiktor, Medtronic Inc., Minne- 
apolis, Minn.) is constructed of a single tantalum wire 
(0.127 mm in diameter) that is formed into a sinusoidal 
wave and wrapped into a helical coil structure. This pros- 
thesis is crimped onto the deflated polyethylene balloon of 
a standard angioplasty catheter. The features of this pros- 
thesis design are such that by inflating the balloon the di- 
ameter of the stent increases without alteration of its 
length.14 The maximal diameter of the balloon after infla- 
tion determines the ultimate size of the prosthesis after 
implantation. One inflation at 8 atm is sufficient to open the 
stent and permit the safe withdrawal of the deflated 
balloon (Fig. 2). The balloon diameters of the mounted an- 
gioplasty catheters used in this study were 4.0 mm, and the 
lengths of the prostheses were 14 to 16 mm. 
Intervention. From the angiograms the patent grafts 
were divided into four groups by visual assessment (Table 
I). A first group of eight grafts (12 anastomotic sites) was 
considered to manifest mild stenoses and an intervention 
was not performed in these grafts to allow the study of 
progression of vein graft hyperplasia. A second group of six 
grafts was dilated by a 4.0 mm angioplasty balloon up to 8 
atm for 40 seconds. A third group of 12 grafts received a 
single 4.0 mm stent covering the narrowest arteriovenous 
anastomosis. A last group of six grafts received two or three 
stents covering both anastomotic sites and the body of the 
graft. The implantation procedure of the 4.0 mm balloon- 
expandable stents was similar to the procedures described 
earlier for the coronary circulation.i4 After stent implanta- 
tion and balloon dilatation repeat angiography was per- 
formed, the guiding catheter and the introducer sheath 
were removed, the arteriotomy was repaired, and the skin 
was closed in two layers. The animals were allowed to re- 
cover from anesthesia. After the procedure, antithrombotic 
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Fig. 2. The Wiktor stent mounted on the balloon before inflation (top) and after inflation of the balloon 
(bottom). 
drugs were not administered at any time during the Table I. Number of animals, grafts, and patency rates per 
follow-up period. intervention group 
Follow-up angiography and harvesting of the speci- 
men. Follow-up angiography was performed after 31 days 
using the same projection and identical geometry of the 
x-ray gantry as used during implantation. Thereafter the 
carotid arteries were dissected free. After cross-clamping 
and puncturing of the proximal part of the arteries, 500 ml 
of saline followed by 400 ml of buffered 4 % paraformalde- 
hyde was infused under a pressure of approximately 120 
mm Hg. The specimens were placed in 4% paraformalde- 
hyde for light microscopy, or in 4 % paraformaldehyde plus 
14, glutaraldehyde in phosphate buffer (pH 7.3) for at least 
48 hours in preparation for electron microscopy. 
Animals 
Intervention group (4 
No intervention 7 
Balloon angioplasty 6 
Single dent 12 
Multiple stent 6 
*p < 0.05 versus other treatment groups. 
Grafts Patency 
fn) C%) 
8 83 
6 83 
12 92 
6 17* 
Angiographic analysis. Angiograms (performed imme- 
diately before and after intervention and again after 31 
days) were analyzed off-line using the quantitative Car- 
diovascular Measuring System (CMS) software (Medis 
Medical Imaging Systems, Nuenen, The Netherlands).15 
The minimal luminal diameter at the site of the interven- 
tion was measured, provided that the angiographic view 
was not obstructed by the hemoclip. 
sectioning and staining, microscopy was performed using a 
light microscope (BH2; Olympus, Tokyo, Japan). Hema- 
toxylin-azophloxin was used as a routine stain, resorcinl- 
fuchsin was used as an elastin stain, and Goldner was used 
as a trichrome stain. 
Microscopic analysis. After fixation, the graft-contain- 
ing arterial segments were divided lengthwise into two 
equal parts using a pair of fine scissors. One part was 
washed in 0.1 mol/L cacodylate buffer (pH 7.3) and was 
postfixed in 1 YO 0~04 in 0.1 mol/L cacodylate buffer for at 
least 6 hours. After it was washed overnight in 0.1 mol/L 
cacodylate buffer, the specimen were placed in 1% tannic 
acid for 60 minutes, in 1 ‘Z sodium sulfate for 10 minutes, 
and was again washed in 0.1 mol/L cacodylate buffer. Af- 
ter dehydration in a graded ethanol series and an overnight 
incubation in uranyl acetate/ethanol (7 parts ethanol 
100%; 3 parts uranyl acetate saturated in aqua de&), the 
specimens were critical point dried with liquid COz, 
mounted on a specimen table, and sputtercoated with gold 
before examination in a scanning electron microscope 
(ISI-DS-130; Akashi Beam Technology, Tokyo, Japan). 
Immunocytochemistry. After rehydration, the sections 
were exposed to monoclonal mouse anti-smooth muscle 
cell-specific cu-actin (Sigma Chemical Company, St Louis, 
MO.), mouse monoclonal anti-porcine vimentin, and mouse 
anti-porcine desmin (Dakopatts, Glostrup, Denmark) as a 
marker for smooth muscle cells. As a second antibody, 
horseradish peroxidase-labeled rabbit anti-mouse anti- 
bodies were used (Dakopatts). As a detecting reagent 700 
pg/ml of diaminobenzidine (Sigma Chemical Company) in 
phosphate-buffered saline was used. 
Statistical analysis. All data are expressed as 
mean -t SEM, unless otherwise stated. Differences in pa- 
tency between the intervention groups were analyzed by 
the chi square test. The significance of the changes in the 
angiographic data were evaluated by Duncan’s new multi- 
ple range test once an analysis of variance (ANOVA) had 
revealed that the samples represented different popula- 
tions (random block design). A p value less than 0.05 was 
considered statistically significant. 
RESULTS 
For light microscopy and immunocytochemistry, 3 to 4 
mm wide transverse sections of the second part of the ves- 
sels were made with a pair of fine scissors and a sharp razor 
blade. With tweezers and with the aid of a dissection mi- 
croscope, the metal stent wires were carefully removed and 
the tissue was dehydrated and embedded in paraffin. After 
Vein graft model. Repeat angiography 31 days after 
surgery showed that 32 grafts (20 animals) out of a 
total of 58 grafts were angiographically patent (45 % 
occlusion rate). All occluded grafts were blocked over 
their entire length, and were excluded from further 
study. 
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Fig. 3. A, Scanning electron microscopy of a 31-day-old vein graft 2 hours after implantation of the stent 
revealed trenches (arrow) where the stent wires were located before preparation for microscopy, with 
thrombus remnants in close apposition (arrowhead). Damage to the vessel wall seems limited to the 
trenches created by the stent wires, while the remaining endothelium appears undamaged. B, Detail of A 
showing the apparently undamaged endothelium just above the stent wire. 
Hemodynamics during intervention. Immediately be- 
fore intervention in the grafts, the heart rate was 
105 + 5 beats/min, and systolic and diastolic arterial 
blood pressure measured 129 * 5 and 93 ? 5 mm 
Hg, respectively. 
Acute effect of stenting. The acute effect of stenting 
was studied by scanning electron microscopy in one 
animal 4 weeks after surgery at 2 hours after stent 
placement. The luminal appearance of the vein graft 
had a waveform geometry after placement of the 
stent. Because of the open sinusoidal configuration, 
parts of the vessel wall not covered by the wires were 
bulging out into the lumen (Fig. 3, A). At a higher 
magnification an undulating surface was seen that 
had an undamaged appearance and that was lined by 
endothelium. Damage to the vessel wall was only ob- 
served at the site where previously the stent wires 
had been present (Fig. 3, B). 
Angiographic patency 4 weeks after intervention. 
Qualitative assessment of the angiograms of the four 
groups revealed that the patency rates after 4 weeks 
of follow-up of the groups receiving no intervention, 
those receiving balloon dilatation, or those with a 
single stent were 83 ‘% , 83 76, and 92 7% , respectively 
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No intervention Balloon angioplasty 
Multiple stents Single stent 
After After 
A 2.2 z o.3 2.7 c 0.2 0.3 2 0.2 2.6 2 0.3 3.4 c 0.6 2.9 f 0.6 
No intervention Balloon angioplasty 
I 
E&e 
i 
After Follow up t&S After Follow up 
N.A. 0.1 e 0.3 N A. 0.6 c 0.3 -0.6 k 0.6 
Multiple stents Single stent 
I 
me, Follow-“p &ore after FOIIOW-UP 
0.5 e 0.2 -2.4 2 0.2 N.A. 0.6 + 0.3 -0.5 + 0.6 
Fig. 4. A, Individual angiographic data and mean minimal luminal diameter (mm t- SEM) at the site of 
intervention before and after intervention and after 4 weeks of follow-up. B, Individual data and mean 
(+ SEM) of the loss or gain in minimal luminal diameter after intervention and after 4 weeks of follow-up. 
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Fig. 5. Overview of a narrowed vein graft. The completely endothelialized graft shows both medial fiW 
and intimal fr) hyperplasia, consisting of smooth muscle cells within a collagenous matrix. A, Adventitia: 
(Goldner trichrome stain; original magnification X10.) 
Fig. 8. Detail of a graft after stent implantation. Near the 
voids that remain after removal of the wires (*), thrombus 
remnants (arrow) are still conspicuously present 1 month 
after implantation of the prosthesis. L, Lumen; I, intima. 
(Goldner trichrome stain; original magnification x40.) 
(Table I). In the group receiving multiple stents, 
however, only 17% proved to be patent (p < 0.05 vs 
all groups). 
Quantitative angiographic analysis. In all grafts the 
minimal luminal diameter (MLD) was localized at an 
anastomotic site. The baseline data show (Fig. 4, A) 
that the mean MLDs of the intervention groups were 
smaller than those of the no intervention group, but 
not significantly different. Balloon dilatation, as well 
as the placement of single or multiple stents, resulted 
in a similar immediate improvement of the mean an- 
giographic MLD (0.6 it- 0.3,0.8 +- 0.3, and 0.5 + 0.2 
mm, respectively; Fig. 4, B). After 4 weeks of follow- 
up, no change was observed in the mean MLD of the 
group without intervention, although some changes 
in lumen diameter were observed (Fig. 4, B). All in- 
tervention groups showed a significant deterioration 
of MLD (p < 0.05) when compared with the diame- 
ter after intervention, resulting in loss of the initial 
gain. Although the loss of mean MLD during fol- 
low-up tended to be smaller for the single stent group 
compared with the balloon group, this difference be- 
tween the groups did not reach levels of statistical 
significance. The loss in MLD of the multiple stent 
group (2.4 f 0.2 mm), however, was significantly 
larger when compared with that of all other groups 
(Fig. 4, B; p < 0.05) because of the high occlusion rate 
of 83 % . When considering only those grafts that re- 
mained patent throughout the study, we found that 
for both balloon angioplasty and single stenting there 
was no decrease in mean MLD throughout the 
follow-up period. Only multiple stenting was associ- 
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Fig. 7. Scanning electron microscopy of a vein graft 4 weeks after implantation of the stent. Note that not 
all wires have become embedded in the vessel wall furrow). 
ated with a net decrease in mean MLD (by 1.9 * 0.3 
mm). 
Histology of the vein graft. The gross morphology of 
the grafts was variable. Both tight stenoses at the 
anastomoses and aneurysmal dilatation of the body 
of the grafts were frequently observed. The adjacent 
carotid artery was usually normal. In all treated as 
well as untreated grafts, we observed both medial and 
neointimal thickening, which consisted of smooth 
muscle cells (confirmed with a positive staining for 
anti-smooth muscle cell-specific clc-actin at immuno- 
cytochemistry) in a collagenous matrix (Fig. 5). Most 
graft segments contained hemosiderin-filled macro- 
phages and inflammatory infiltrates. At the anasto- 
moses we observed inflammatory reactions surround- 
ing the suture and the hemoclip. Macrophages were 
found containing crystalline inclusions, indicating 
that the inflammatory response was indeed directed 
to the 6.0 suture (Prolene, Ethicon, Inc., Somerville, 
N.J.). In the single stent treatment group, we ob- 
served that 4 weeks after stent implantation throm- 
bus remnants surrounding the metal wires were con- 
spicuously present (Fig. 6). The metal wires were not 
always embedded in the vessel wall (Fig. 7). Also, in- 
flammatory infiltrates surrounding the stent wires 
were observed in the neointima, as well as an occa- 
sional multinucleate giant cell. The adjacent carotid 
arterial side of the anastomosis was less affected. 
DISCUSSION 
Porcine model of autologous saphenous vein grafting. 
The autologous saphenous vein is still the most com- 
mon conduit for aortocoronary bypass grafts in 
humans. The vein graft model used in this study 
(overdistended vena saphena minor interposed in the 
arteria carotis communis by two end-to-end anasto- 
moses)13 shows extensive intimal hyperplasia that is 
histologically similar to early graft failure in humans 
(Fig. 8). In this model we compared the behavior of 
single or multiple balloon-expandable Wiktor stents 
with the results of balloon angioplasty alone or with 
the results of no intervention. 
Acute effect of stenting of the 31-day-old vein graft. 
Scanning electron microscopy revealed that except 
for the visible damage directly underneath the wires, 
no apparent damage to the vessel wall was inflicted 
by the implantation procedure, as demonstrated by 
the microscopically normal endothelium. Because of 
the coil configuration of the stent, however, the 
luminal side was not smooth after the procedure (Fig. 
3, A). The resulting flow disturbances might in turn 
induce thrombus deposition and persistent endothe- 
lial damage, which may both influence the process of 
intimal hyperplasia. 
Angiography. From the angiograms the grafts were 
classified during the procedure qualitatively (by 
visual assessment) either as having only mild stenoses 
(later quantitatively analyzed as 32 5%) range 23 % to 
60%), in which case no further treatment was given, 
or as having severe stenoses (48%, range 19% to 
70 % ), in which case they were assigned to either bal- 
loon angioplasty, single stenting, or multiple stent- 
ing. Although some differences in angiographic MLD 
were observed between the intervention groups 
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Fig. 8. Early graft failure in humans resembles graft failure in pigs, both showing medial and intimal hy- 
perplasia and excessive extracellular matrix production. Z Intima; M, media; A, adventitia V, valve. (Gold- 
ner trichrome stain; original magnification x10.) 
(Fig. 4, A), these differences were not statistically 
significant. In these groups angiography was again 
performed directly after the intervention. Compari- 
son with the no intervention group revealed that only 
in the case of single stenting was a similar MLD 
created (Fig. 4, B). 
During the 4 weeks of follow-up, a significant de- 
terioration occurred in the mean MLD of all treat- 
ment groups. It seems, however, from the angio- 
graphic data of the grafts that remained patent 
throughout the study (Table I and Fig. 4, A and B) 
that for the single stent and balloon angioplasty 
groups there are only two possible results in the final 
outcome. Either the increase in MLD after interven- 
tion is maintained or treatment results in total 
occlusion. Single stenting, however, does seem able to 
better maintain the procedural increase in MLD than 
balloon angioplasty alone (Fig. 4, B). 
Histology and immunocytochemistry. Human saphe- 
nous vein bypass grafts studied within 1 month after 
surgery reveal minimal to mild fibrointimal hyper- 
plasia. Some of this narrowing may well be preexist- 
ing, since Thiene et a1.i6 reported that of 150 grossly 
“normal” veins, only 10 were totally free of micro- 
scopic phlebosclerosis. The porcine vein grafts from 
our study exhibited a more extensive fibrointimal 
hyperplasia. The high occlusion rate of 45 % is likely 
to be the result of overdistention-induced injury and 
thrombosis superimposed on intimal hyperplasia, as 
indicated by hemosiderin deposits and neovascular- 
ization. Following stent implantation, plasma pro- 
teins, platelets, and leukocytes adhere to the metal 
wires. When compared with healthy, normal vessels, 
the thrombotic response to injury tends to be more 
pronounced in vessels with a previous history of dis- 
ease such as intimal thickening,i7 and might act in 
synergy with the stent. 
From the histology of stented anastomotic sites, we 
observed that the intimal thickening was more pro- 
nounced in the grafts than in the adjacent “normal” 
carotid artery. Additionally, thrombus remnants that 
were still conspicuously present in the graft in close 
apposition to the stent wires were cleared in the ca- 
rotid artery within the same period. This indicates 
that either the thrombotic response to this type of 
injury is indeed more pronounced, or that the orga- 
nization of the thrombus is delayed or impaired in the 
graft. More likely is a combination of both, since the 
incomplete incorporation of the stent in the vessel 
wall is indicative of a slow-healing wound. In addi- 
tion, histologic examination of stents in older human 
vein grafts revealed the persistence of thrombus 
remnants.t2 
Balloon angioplasty versus stenting with single or 
multiple endoprostheses. In this model of early sa- 
phenous vein graft stenosis, balloon angioplasty and 
single stents resulted in comparable short-term pa- 
tency rates and mean MLD. Preliminary clinical re- 
sults of placement of a self-expanding metal stent in 
older vein grafts suggest that this treatment has a 
more favorable clinical course when compared with 
that of balloon angioplasty.16 The implantation of 
multiple stents, however, yielded significantly more 
luminal narrowing at follow-up in our experiments. 
Therefore our results suggest that the implantation 
of multiple stents is not indicated in early bypass 
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graft failure. Whether the same applies to late vein 
graft stenosis remains to be determined, but prelim- 
inary reports indicate that in humans, multiple 
stenting is indeed associated with an increased risk 
for restenosis.18 
Limitations of the study. Several factors may limit 
the conclusions from this study: (1) The nonrandom 
distribution of grafts may have been an advantage for 
the “no intervention” group, because their initial di- 
ameter was larger than that of the others. The mean 
diameter of the grafts that remained patent through- 
out the study also indicate this to be an important 
parameter. Although some controversy still exists on 
the importance of the initial diameter, it was found 
that a small vessel diameter increased the risk of 
stent thrombosis, as did the use of small stent sizes.rg 
(2) Histologic analysis showed that at 2 months 
inflammatory infiltrates were still present in the un- 
treated grafts and especially at the anastomotic sites. 
The relatively early interventions (only 1 month af- 
ter grafting) while healing was still ongoing may have 
elicited a second more pronounced inflammatory 
process, which may have disturbed wound healing 
and increased intimal and medial hyperplasia or even 
promoted (secondary) thrombotic occlusion. Better 
results may be expected if the intervention is delayed 
until healing of the vessel wall is completed. 
Conclusions. The present study shows that single 
stenting and balloon angioplasty seem able to main- 
tain the increase in MLD during follow-up when 
patent grafts only are considered, and in the case of 
single stenting there is less variability. Overall, how- 
ever, these techniques do not decrease or signifi- 
cantly improve patency (as assessed by angiography) 
when stents are placed early (within 31 days) after 
grafting. Multiple stenting of porcine saphenous vein 
carotid bypass grafts, however, results in decreased 
patency. Additional antithrombotic therapy might 
have yielded better results. 
We thank Robert van Bremen for his technical assistance and 
indispensable help during the experiments. 
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